FDA Reviewers Spot Safety Concerns With Sanofi, Isis Lipid Drug

17.10.2012 - U.S. drug reviewers flagged several safety concerns, including possible cancer risks, related to Sanofi and Isis Pharmaceuticals's lipid disorder drug Kynamro, sending Isis's...